3.15
Protagenic Therapeutics Inc Azioni (PTIX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
|
11.87%
1.4481
|
1.6432 | 0.6521 | 1.6673 | 1.7384 |
Operating Income/Loss |
11.87%
-1.4481
|
-1.6432 | -0.6521 | -1.6673 | -1.7384 |
Nonoperating Income/Loss |
90.94%
0.0081
|
0.0894 | 0.0113 | 0.0608 | 0.0141 |
Income/Loss From Continuing Operations Before Tax |
7.32%
-1.44
|
-1.5537 | -0.6408 | -1.6065 | -1.7243 |
Income/Loss From Continuing Operations After Tax |
7.32%
-1.44
|
-1.5537 | -0.6408 | -1.6065 | -1.7243 |
|
7.32%
-1.44
|
-1.5537 | -0.6408 | -1.6065 | -1.7243 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
21.54%
0.5232
|
0.4305 | 4.5291 | 4.4432 | 4.4351 |
Diluted Average Shares |
21.54%
0.5232
|
0.4305 | 4.5291 | 4.4432 | 4.4351 |
Basic Earnings Per Share |
1,046%
-2.75
|
-0.24 | -0.14 | -0.36 | -0.39 |
Diluted Earnings Per Share |
1,046%
-2.75
|
-0.24 | -0.14 | -0.36 | -0.39 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):